Periodic Reporting for period 2 - CARsen (Senolytic CAR T cells as novel therapeutic concept for solid tumors and senescence-associated diseases.)

Cell therapies with genetically engineered immune cells expressing chimeric antigen receptors (“CARs”) have shown great success against certain hematological diseases, leading to the approval of CAR T cell products for specific indications. However, several challenges have...